Loading...
Lurasidone: A New Treatment Option for Bipolar Depression—A Review
Depressive episodes in bipolar disorder contribute to significant morbidity and mortality. Until recently, only quetiapine and an olanzapine-fluoxetine combination were approved to treat bipolar depression. Recently, lurasidone was approved to treat bipolar depression either as monotherapy or adjunc...
Saved in:
| Published in: | Innov Clin Neurosci |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Matrix Medical Communications
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4382136/ https://ncbi.nlm.nih.gov/pubmed/25852975 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|